23.87 -0.20 (-0.83%)

57.14% Gain from 52W Low

1.2M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for NewAmsterdam Pharma Company NV

The latest disclosure was made by Douglas F. Kling in NewAmsterdam Pharma Company NV where a trade of 88,112 Ordinary Shares done was reported to US exchanges on March 17, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Mar 2025 88,112 132,112 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. 17 Mar 2025 11,888 144,000 - 10 118,880 Ordinary Shares
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Mar 2025 88,112 47,251 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Mar 2025 11,888 650,930 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Mar 2025 100,000 44,000 - - Ordinary Shares
Louise Kooij Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2025 150,000 165,000 - - Ordinary Shares
Louise Kooij Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2025 150,000 18,073 - - Option (right to buy)
Louise Kooij Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 20.37 per share. 04 Mar 2025 150,000 15,000 - 20.4 3,055,500 Ordinary Shares
James N. Topper Director Purchase of securities on an exchange or from another person at price $ 21.02 per share. 04 Mar 2025 4,005 3,012,434 - 21.0 84,203 Ordinary Shares
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2025 90,782 134,782 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Feb 2025 90,782 44,000 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2025 9,218 53,218 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Feb 2025 9,218 44,000 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2025 90,782 135,363 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Feb 2025 9,218 126,145 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2025 56,863 239,723 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2025 13,578 226,145 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2025 56,863 100,863 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Jan 2025 56,863 44,000 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Jan 2025 8,914 44,000 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 29 Jan 2025 4,664 52,914 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jan 2025 13,578 57,578 - - Ordinary Shares
Ian Somaiya Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jan 2025 33,679 51,304 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 104,174 321,971 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 25,385 296,586 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 104,174 148,174 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jan 2025 80,359 67,815 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jan 2025 23,815 44,000 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 25,385 69,385 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jan 2025 20,237 49,148 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jan 2025 5,148 44,000 - - Ordinary Shares
Ian Somaiya Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 14,900 762,814 - - Option (Right to Buy)
Ian Somaiya Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.26 per share. 27 Jan 2025 14,900 52,900 - 9.3 137,974 Ordinary Shares
Ian Somaiya Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jan 2025 11,495 41,405 - - Ordinary Shares
Ian Somaiya Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jan 2025 3,405 38,000 - - Ordinary Shares
Ian Somaiya Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jan 2025 46,983 777,714 - - Option (Right to Buy)
Ian Somaiya Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.26 per share. 27 Jan 2025 46,983 84,983 - 9.3 435,063 Ordinary Shares
Ian Somaiya Chief Financial Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Jan 2025 13,304 38,000 - - Ordinary Shares
Ian Somaiya Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2025 38,000 38,000 - - Ordinary Shares
Johannes Jacob Pieter Kastelein Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2025 34,000 34,000 - - Ordinary Shares
Juliette Audet Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2025 14,000 15,104 - - Ordinary Shares
Louise Kooij Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2025 15,000 15,000 - - Ordinary Shares
Douglas F. Kling Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2025 44,000 44,000 - - Ordinary Shares
William B.J. Jones Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2025 43,000 43,000 - - Ordinary Shares
John W. Smither Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 32,500 32,500 - - Option (right to buy)
Janneke van der Kamp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 6,960 6,960 - - Ordinary Shares
Michael Harvey Davidson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 123,529 123,529 - - Ordinary Shares
Janneke van der Kamp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 32,500 32,500 - - Option (right to buy)
Michael Harvey Davidson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 670,467 670,467 - - Option (right to buy)
Louis G. Lange Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 6,960 6,960 - - Ordinary Shares
Louis G. Lange Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 32,500 32,500 - - Option (right to buy)
William H. Lewis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 6,960 6,960 - - Ordinary Shares
William H. Lewis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 32,500 32,500 - - Option (right to buy)
John W. Smither Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 6,960 6,960 - - Ordinary Shares
Mark C. McKenna Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 32,500 32,500 - - Option (right to buy)
Mark C. McKenna Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 6,960 6,960 - - Ordinary Shares
Louise Kooij Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 80,000 80,000 - - Option (right to buy)
Juliette Audet Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 100,000 100,000 - - Option (right to buy)
Johannes Jacob Pieter Kastelein Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 200,000 200,000 - - Option (right to buy)
Ian Somaiya Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 220,000 220,000 - - Option (right to buy)
Douglas F. Kling Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 250,000 250,000 - - Option (right to buy)
William B.J. Jones Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2025 200,000 200,000 - - Option (right to buy)
Michael Harvey Davidson Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 09 Oct 2024 15,000 85,000 - - Warrant (right to buy)
Louise Kooij Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Sep 2024 45,000 45,000 - - Ordinary Shares
Louise Kooij Chief Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Sep 2024 45,000 168,073 - - Option (right to buy)
Louise Kooij Chief Accounting Officer Sale of securities on an exchange or to another person at price $ 15.72 per share. 27 Sep 2024 45,000 0 - 15.7 707,400 Ordinary Shares
Juliette Audet Chief Business Officer Purchase of securities on an exchange or from another person at price $ 15.70 per share. 26 Sep 2024 1,104 1,104 - 15.7 17,333 Ordinary Shares
Michael Harvey Davidson Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 16.27 per share. 20 Aug 2024 5,000 209,784 - 16.3 81,350 Ordinary Shares
Mark C. McKenna Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2024 72,500 72,500 - - Option (right to buy)
Michael Harvey Davidson Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 17.26 per share. 20 Jun 2024 5,000 204,784 - 17.3 86,309 Ordinary Shares
Juliette Audet Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2024 250,000 250,000 - - Option (right to buy)
Johannes Jacob Pieter Kastelein Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Mar 2024 201,673 201,673 - - Ordinary Shares
Johannes Jacob Pieter Kastelein Director, Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.72 per share. 26 Mar 2024 11,197 190,476 - 22.7 254,396 Ordinary Shares
Johannes Jacob Pieter Kastelein Director, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Mar 2024 201,673 970,229 - - Option (right to buy)
Johannes Jacob Pieter Kastelein Director, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 21.50 per share. 26 Mar 2024 190,476 0 - 21.5 4,095,234 Ordinary Shares
James N. Topper Director Purchase of securities on an exchange or from another person at price $ 21.50 per share. 26 Mar 2024 8,429 3,008,429 - 21.5 181,224 Ordinary Shares
Louis G. Lange Director Purchase of securities on an exchange or from another person at price $ 19.00 per share. 13 Feb 2024 5,000 24,878 - 19 95,000 Ordinary Shares
William H. Lewis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2024 100,000 100,000 - - Option (right to buy)
Ian Somaiya Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 80,000 80,000 - - Option (right to buy)
Davidson Harvey Michael Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 1,039,939 1,039,939 - - Option (right to buy)
F. Douglas Kling Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 323,771 323,771 - - Option (right to buy)
Louise Kooij Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 150,494 150,494 - - Option (right to buy)
G. Lange Louis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 10,000 10,000 - - Option (right to buy)
W. Smither John Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 10,000 10,000 - - Option (right to buy)
Kastelein Jacob Pieter Johannes Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 500,000 500,000 - - Option (right to buy)
Janneke van der Kamp Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2024 10,000 10,000 - - Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures